SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

RAPEZZI, Claudio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.563
AS - Asia 7.898
EU - Europa 4.836
SA - Sud America 1.879
AF - Africa 181
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 5
Totale 24.377
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.237
SG - Singapore 3.852
IT - Italia 1.704
BR - Brasile 1.542
CN - Cina 1.382
PL - Polonia 1.183
HK - Hong Kong 1.074
VN - Vietnam 765
DE - Germania 452
ID - Indonesia 322
GB - Regno Unito 320
RU - Federazione Russa 301
FI - Finlandia 204
MX - Messico 201
UA - Ucraina 144
AR - Argentina 134
NL - Olanda 118
SE - Svezia 114
CA - Canada 95
ZA - Sudafrica 90
TR - Turchia 86
IN - India 82
BD - Bangladesh 69
JP - Giappone 66
FR - Francia 65
EC - Ecuador 59
AT - Austria 58
CO - Colombia 40
IQ - Iraq 36
ES - Italia 29
PK - Pakistan 29
MA - Marocco 23
CL - Cile 21
CH - Svizzera 20
PY - Paraguay 20
VE - Venezuela 20
LT - Lituania 15
PE - Perù 15
UY - Uruguay 15
BE - Belgio 13
JO - Giordania 13
EG - Egitto 12
IE - Irlanda 12
SA - Arabia Saudita 12
TN - Tunisia 12
AU - Australia 11
CZ - Repubblica Ceca 11
NP - Nepal 11
BO - Bolivia 10
IR - Iran 10
UZ - Uzbekistan 10
AE - Emirati Arabi Uniti 9
AZ - Azerbaigian 9
RO - Romania 9
KZ - Kazakistan 8
LY - Libia 8
MY - Malesia 8
BG - Bulgaria 7
KE - Kenya 7
PT - Portogallo 7
BY - Bielorussia 6
DZ - Algeria 6
SN - Senegal 6
AL - Albania 5
DO - Repubblica Dominicana 5
GR - Grecia 5
HN - Honduras 5
HR - Croazia 5
IL - Israele 5
KR - Corea 5
LB - Libano 5
MD - Moldavia 5
NG - Nigeria 5
RS - Serbia 5
TW - Taiwan 5
NI - Nicaragua 4
NZ - Nuova Zelanda 4
CY - Cipro 3
EE - Estonia 3
GT - Guatemala 3
JM - Giamaica 3
KG - Kirghizistan 3
PH - Filippine 3
SV - El Salvador 3
AM - Armenia 2
AO - Angola 2
BN - Brunei Darussalam 2
BQ - ???statistics.table.value.countryCode.BQ??? 2
BW - Botswana 2
CG - Congo 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DK - Danimarca 2
EU - Europa 2
GA - Gabon 2
GE - Georgia 2
GY - Guiana 2
HU - Ungheria 2
LU - Lussemburgo 2
LV - Lettonia 2
Totale 24.350
Salva come PNG Salva come JPEG
Città #
Singapore 1.931
Warsaw 1.172
Ashburn 1.069
Hong Kong 1.068
Fairfield 1.009
Santa Clara 884
Beijing 686
Woodbridge 540
Houston 456
Wilmington 418
Seattle 370
Cambridge 338
Chandler 335
Princeton 308
Jakarta 283
Ho Chi Minh City 239
Ann Arbor 189
Dallas 163
Los Angeles 155
New York 154
Milan 151
Mexico City 144
Moscow 141
Rome 140
San Diego 137
Munich 136
Hanoi 130
São Paulo 126
Chicago 118
Helsinki 108
Jacksonville 105
London 100
Dong Ket 93
Shanghai 82
Nuremberg 78
Bologna 61
Ferrara 59
Turku 56
Rio de Janeiro 53
Falls Church 51
Naples 48
Tianjin 44
Tokyo 43
Florence 41
Stockholm 38
Denver 37
Belo Horizonte 36
Brooklyn 34
Boardman 33
Palermo 33
Haiphong 32
Izmir 32
Johannesburg 32
Montreal 31
Redwood City 31
Bremen 30
Nanjing 30
Poplar 28
Buffalo 27
Orem 27
Brasília 26
Da Nang 26
Norwalk 26
Salt Lake City 26
Bari 24
Phoenix 24
Toronto 24
Chennai 23
Frankfurt am Main 23
Boston 22
Quito 21
Atlanta 20
Curitiba 20
Mountain View 20
Campinas 19
Lappeenranta 19
Vienna 19
Guayaquil 18
Hải Dương 18
Porto Alegre 18
Turin 18
Guarulhos 17
Manchester 17
Messina 17
Kilburn 16
Redmond 16
San Francisco 16
Ankara 15
Baghdad 15
Buenos Aires 15
Dhaka 15
Guangzhou 15
Salvador 15
Santo André 15
Brescia 14
Hounslow 14
Verona 14
Amman 13
Biên Hòa 13
Düsseldorf 13
Totale 15.262
Salva come PNG Salva come JPEG
Nome #
Documento di consenso ANMCO/SIC sulla gestione delle miocarditi 791
Linee guida ESC 2015 per il trattamento dell'endocardite infettiva: Task Force per il Trattamento dell'Endocardite Infettiva della Società Europea di Cardiologia (ESC): Con il patrocinio dell'Associazione Europea di Chirurgia Cardiotoracica (EACTS) e dell'Associazione Europea di Medicina Nucleare (EANM) 410
POPDC1S201F causes muscular dystrophy and arrhythmia by affecting protein trafficking 385
Antisense modulation of both exonic and intronic splicing motifs induces skipping of a DMD pseudo-exon responsible for X-linked dilated cardiomyopathy 198
Heart failure with preserved ejection fraction: uncertainties and dilemmas 194
The absence of dystrophin brain isoform expression in healthy human heart ventricles explains the pathogenesis of 5 ' X-linked dilated cardiomyopathy 186
Defining the Diagnosis in Echocardiographically Suspected Senile Systemic Amyloidosis 181
Effects of cardiac resynchronisation therapy on dilated cardiomyopathy with isolated ventricular non-compaction 178
Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective 177
Gender-related risk of myocardial involvement in systemic amyloidosis 171
Long-term safety of drug-eluting and bare-metal stents: Evidence from a comprehensive network meta-analysis 165
Phenotypic profile of Ile68Leu transthyretin amyloidosis: an underdiagnosed cause of heart failure 163
Role of 99mTc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis 159
Antibiotic prophylaxis based on individual infective risk stratification in cardiac implantable electronic device: the PRACTICE study 157
Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role 155
La diagnosi elettrocardiografica di infarto miocardico acuto nell'era dell'angioplastica primaria e delle reti hub and spoke 154
Treatment of cardiac transthyretin amyloidosis: An update 148
Acute heart failure in patients with acute aortic syndrome: Pathophysiology and clinical-prognostic implications 145
COVID-19 in the heart and the lungs: could we “Notch” the inflammatory storm? 145
Adherence to agents acting on the renin-angiotensin system in secondary prevention of non-fatal myocardial infarction: a self-controlled case-series study 144
ARNIs: balancing “the good and the bad” of neuroendocrine response to HF 142
Phenotypic and genotypic heterogeneity in transthyretin-related cardiac amyloidosis: towards tailoring of therapeutic strategies? 140
Neurohormones and inflammatory mediators in patients with heart failure undergoing cardiac resynchronization therapy: Time courses and prediction of response 140
Electrocardiographic features of 431 consecutive, critically ill COVID-19 patients: An insight into the mechanisms of cardiac involvement 138
Functional characterization of two novel mutations in scn5a associated with brugada syndrome identified in Italian patients 136
Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types 135
Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis 131
The Mediterranean diet: a cultural journey 127
A targeted proteomics approach to amyloidosis typing 127
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization-the first insight from the AC-TIVE Study 127
Atherosclerotic aortic lesions increase the risk of cerebral embolism during carotid stenting in patients with complex aortic arch anatomy 126
'Corona' versus 'coronary' 126
Coronary and total thoracic calcium scores predict mortality and provides pathophysiologic insights in COVID-19 patients 123
Broadening the Phenotypic Spectrum and the Diagnostic Needs of TTR-Related Cardiac Amyloidosis 122
Carpal tunnel syndrome in cardiac amyloidosis: implications for early diagnosis and prognostic role across the spectrum of aetiologies 121
2019 CORONAVIRUS: What are the implications for cardiology? 121
Nonbiopsy diagnosis of cardiac transthyretin amyloidosis 120
Cardiopulmonary exercise testing predicts prognosis in amyloid cardiomyopathy: a systematic review and meta-analysis 118
Diastolic dysfunction, frailty and prognosis in elderly patients with acute coronary syndromes 117
The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification 117
Differences in cardiac phenotype and natural history of laminopathies with and without neuromuscular onset 116
Left ventricular myocardial noncompaction with advanced atrioventricular conduction disorder and ventricular arrhythmias in a young patient: Role of MIB1 gene 116
Antithrombotic Management during Percutaneous Mitral Valve Repair with the Mitraclip System in a Patient with Heparin-Induced Thrombocytopenia 115
Prediction of thrombo-embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk-CVA) 115
Effectiveness of the 2014 European Society of Cardiology guideline on sudden cardiac death in hypertrophic cardiomyopathy: A systematic review and meta-analysis 115
The Residual Risk of Cerebral Embolism after Carotid Stenting: The Complex Interplay between Stent Coverage and Aortic Arch Atherosclerosis 114
A Pathogenic Galactosidase A Mutation Coexisting With an MYBPC3 Mutation in a Female Patient With Hypertrophic Cardiomyopathy 114
Current evidence on the diagnostic and prognostic role of native T1 mapping in heart diseases 113
Looking for a tailored therapy for heart failure: Are we capable of treating the patient instead of the disease? 113
Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome - Results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) study 110
Predictors of atrial fibrillation in hypertrophic cardiomyopathy 110
Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice 110
Risk of Adverse Cardiac and Bleeding Events Following Cardiac and Noncardiac Surgery in Patients with Coronary Stent: How Important Is the Interplay between Stent Type and Time from Stenting to Surgery? 109
(18)F-FDG PET/CT diagnosis of unexpected extracardiac septic embolisms in patients with suspected cardiac endocarditis 109
Assessment of patients with hereditary transthyretin amyloidosis–understanding the impact of management and disease progression 109
Troponin T elevation in acute aortic syndromes: Frequency and impact on diagnostic delay and misdiagnosis 106
Myocarditis in COVID-19 patients: current problems 105
Standard ecg in brugada syndrome as a marker of prognosis: From risk stratification to pathophysiological insights 105
Transthyretin amyloidosis in aortic stenosis: clinical and therapeutic implications 105
Atrial Fibrillation in β-Thalassemia: Overview of Mechanism, Significance and Clinical Management 105
Cardiac Calcifications: Phenotypes, Mechanisms, Clinical and Prognostic Implications 104
Progressive brachial plexus enlargement in hereditary transthyretin amyloidosis 104
Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis 102
Criteri di appropriatezza nella gestione della terapia ipocolesterolemizzante con alirocumab nel paziente ad alto rischio cardiovascolare. L’opinione di un gruppo multidisciplinare di esperti italiani [Appropriateness criteria for the management of lipid-lowering therapy with alirocumab in high cardiovascular risk patients. The opinion of a multidisciplinary group of Italian experts] 102
Long-term Follow up of Patients with Acute Aortic Syndromes: Relevance of both Aortic and Non-aortic Events 100
One year on: The impact of COVID-19 on clinical research 100
Left atrial structure and function in cardiac amyloidosis 99
European Cardiomyopathy Pilot Registry: EURObservational Research Programme of the European Society of Cardiology 98
Atrial Flutter in Patient With Critical COVID-19: Beneficial Effects of Rhythm Control on Respiratory Distress 98
Design and Rationale of the Phase 3 ATTR-ACT Clinical Trial (Tafamidis in Transthyretin Cardiomyopathy Clinical Trial) 97
Adapting to survive 97
Phenotypic heterogeneity of COVID-19 pneumonia: clinical and pathophysiological relevance of the vascular phenotypea 97
99mTc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis 97
Left ventricular output indices and sacubitril/valsartan titration: role of stroke volume index 96
Coexistence of Degenerative Aortic Stenosis and Wild-Type Transthyretin-Related Cardiac Amyloidosis 96
Sacubitril/Valsartan: Updates and Clinical Evidence for a Disease-Modifying Approach 95
Relationship between aetiology and left ventricular systolic dysfunction in hypertrophic cardiomyopathy 95
Histopathological comparison of intramural coronary artery remodeling and myocardial fibrosis in obstructive versus end-stage hypertrophic cardiomyopathy 95
Clinical use of doppler echocardiography in organic mitral regurgitation: From diagnosis to patients’ management 95
Multi-imaging investigation to evaluate the relationship between serum cystatin c and features of atherosclerosis in Non-ST-Segment elevation acute coronary syndrome 95
Genetic Screening of Anderson-Fabry Disease in Probands Referred From Multispecialty Clinics 93
State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis 93
Cardiac amyloidosis: the great pretender 93
Performance of Synthetic Extracellular Volume Fraction in Different Cardiac Phenotypes From a Prospective Cohort of Patients Referred for Cardiac Magnetic Resonance 93
Acute myocarditis after SARS-CoV-2 vaccination in a 24-year-old man 93
The battle against COVID-19: Mortality in Italy 93
Impact of clinical and subclinical coronary artery disease as assessed by coronary artery calcium in COVID-19 93
Three-Dimensional Electro-Anatomical Mapping and Myocardial Work Performance during Spontaneous Rhythm, His Bundle Pacing and Right Ventricular Pacing: The EMPATHY Study 92
Neurological involvement in Ile68Leu (p.Ile88Leu) ATTR amyloidosis: not only a cardiogenic mutation 92
Targeted next-generation sequencing helps to decipher the genetic and phenotypic heterogeneity of hypertrophic cardiomyopathy 91
The complex interplay between systolic and diastolic function at rest and during exercise in heart failure: the case of cardiac amyloidosis 91
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2-Diagnostic Criteria and Appropriate Utilization 91
IMPLICAZIONI PRATICHE E NUOVI SCENARI DI PROTEZIONE CARDIOVASCOLARE 91
Stroke volume and myocardial contraction fraction in transthyretin amyloidosis cardiomyopathy: A systematic review 90
2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM) 90
Short- versus long-term dual antiplatelet therapy after drug-eluting stent implantation: An individual patient data pairwise and network meta-analysis 90
null 89
Trastuzumab resumption after extremely severe cardiotoxicity in metastatic breast cancer patient: A case report 89
Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey) 89
A new therapy for transthyretin amyloidosis, no longer an orphan condition 89
Totale 12.961
Salva come PNG Salva come JPEG
Categoria #
all - tutte 197.876
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.257
Totale 199.133
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.993 0 0 0 0 0 335 235 335 235 423 195 235
2021/20221.975 133 87 52 33 73 136 188 188 106 197 209 573
2022/20231.696 323 42 120 92 152 186 124 137 179 86 159 96
2023/20241.368 79 130 74 64 114 122 74 85 49 60 68 449
2024/20256.241 220 88 616 193 650 503 204 184 988 1.227 769 599
2025/20268.529 1.180 712 1.556 2.280 2.083 718 0 0 0 0 0 0
Totale 25.164